Detalhe da pesquisa
1.
Noninvasive detection of any-stage cancer using free glycosaminoglycans.
Proc Natl Acad Sci U S A
; 119(50): e2115328119, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36469776
2.
Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study.
World J Urol
; 34(8): 1081-6, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26847337
3.
Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
Acta Radiol
; 56(12): 1519-26, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25414370
4.
Frequency and radiological characteristics of previously overlooked renal cell carcinoma.
Acta Radiol
; 60(10): 1348-1359, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700094
5.
End-stage renal disease after renal cancer surgery: risk factors and overall survival.
Scand J Urol
; 59: 109-116, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38747153
6.
Predictors for complication in renal cancer surgery: a national register study.
Scand J Urol
; 58: 38-45, 2023 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605443
7.
Long-term efficacy of selective arterial embolisation of renal angiomyolipoma.
Scand J Urol
; 58: 86-92, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37909895
8.
Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma - results from the National Swedish Kidney Cancer Register.
Scand J Urol
; 57(1-6): 67-74, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36520023
9.
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study.
JCO Precis Oncol
; 7: e2200361, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848607
10.
Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma-A Prospective Cohort Study.
Eur Urol Open Sci
; 42: 30-39, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35911082
11.
Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma.
Scand J Urol
; 56(5-6): 383-390, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35983600
12.
Increased risk for renal cell carcinoma in end stage renal disease - a population-based case-control study.
Scand J Urol
; 55(3): 209-214, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33769206
13.
Validation of data quality in the National Swedish Kidney Cancer Register.
Scand J Urol
; 55(2): 142-148, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33599561
14.
Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
Acta Radiol
; 51(7): 808-18, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20707665
15.
Renal angiomyolipoma-patient characteristics and treatment with focus on active surveillance.
Scand J Urol
; 54(2): 141-146, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971051
16.
The renal cell cancer database Sweden (RCCBaSe) - a new register-based resource for renal cell carcinoma research.
Scand J Urol
; 54(3): 235-240, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436435
17.
Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a real-world setting.
Scand J Urol
; 54(6): 487-492, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897123
18.
Metastatic renal cell carcinoma treated with Peg-interferon alfa-2b.
Acta Oncol
; 48(6): 901-8, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19274498
19.
Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis.
Cancer Manag Res
; 11: 1289-1297, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30799955
20.
Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations.
Urol Oncol
; 35(9): 541.e15-541.e22, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28623071